Sector revisions Legend Biotech Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 12/05/2026 BST			5-day change	1st Jan Change
28.26 ^USD	+10.48%		-0.88%	+29.99%

05-12	Legend Biotech Corporation, Q1 2026 Earnings Call, May 12, 2026
05-12	Legend Biotech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
LEGEND BIOTECH CORPORATION				16
ARGENX SE				15
WUXI APPTEC CO., LTD.				17
BIONTECH SE				18
INSMED INCORPORATED				20
WUXI BIOLOGICS (CAYMAN) INC.				21
GENMAB A/S				15
AKESO, INC.				21
SUMMIT THERAPEUTICS INC.				14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
EXELIXIS, INC.				17
MADRIGAL PHARMACEUTICALS, INC.				14
ARROWHEAD PHARMACEUTICALS, INC.				12
CYTOKINETICS, INCORPORATED				19
REMEGEN CO., LTD.				15
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
IMMUNITYBIO, INC.				4
PHARMAESSENTIA CORPORATION				6
NUVALENT, INC.				18
VAXCYTE, INC.				9
Average				14
Weighted average by Cap.				16